English
简体中文
Total: £ 56.28
Published Date: 2024-07-02 | Pages: 99 | Tables: 194 | Medical Care
AI, its end-to-end drug discovery platform using generative artificial intelligence to discover new targets, design new molecules, and predict the outcome of clinical trials.
The global AI-driven Drug Discovery market was valued at US$ 716 million in 2023 and is anticipated to reach US$ 1372.6 million by 2030, witnessing a CAGR of 10.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for AI-driven Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI-driven Drug Discovery.
Report Scope
The AI-driven Drug Discovery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global AI-driven Drug Discovery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI-driven Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Entos
Selvita
Benevolent
Exscientia
Euretos
Illumina with AstraZeneca
Novo Nordisk with Microsoft
Iktos
Aqemia
Zephyr AI
Cyclicarx
Eli Lilly
Terray Therapeutics
Ardigen
ReviveMed
Insilico Medicine
XtalPi
MindRank
DP Technology
Segment by Type
Small Molecule Drug
Biological Modeling
Structural Biology
Others
Segment by Application
Pharmaceutical and Biotechnology Companies
Research Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI-driven Drug Discovery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI-driven Drug Discovery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Small Molecule Drug
1.2.3 Biological Modeling
1.2.4 Structural Biology
1.2.5 Others
1.3 Market by Application
1.3.1 Global AI-driven Drug Discovery Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Research Laboratories
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI-driven Drug Discovery Market Perspective (2019-2030)
2.2 AI-driven Drug Discovery Growth Trends by Region
2.2.1 Global AI-driven Drug Discovery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 AI-driven Drug Discovery Historic Market Size by Region (2019-2024)
2.2.3 AI-driven Drug Discovery Forecasted Market Size by Region (2025-2030)
2.3 AI-driven Drug Discovery Market Dynamics
2.3.1 AI-driven Drug Discovery Industry Trends
2.3.2 AI-driven Drug Discovery Market Drivers
2.3.3 AI-driven Drug Discovery Market Challenges
2.3.4 AI-driven Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI-driven Drug Discovery Players by Revenue
3.1.1 Global Top AI-driven Drug Discovery Players by Revenue (2019-2024)
3.1.2 Global AI-driven Drug Discovery Revenue Market Share by Players (2019-2024)
3.2 Global AI-driven Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by AI-driven Drug Discovery Revenue
3.4 Global AI-driven Drug Discovery Market Concentration Ratio
3.4.1 Global AI-driven Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI-driven Drug Discovery Revenue in 2023
3.5 AI-driven Drug Discovery Key Players Head office and Area Served
3.6 Key Players AI-driven Drug Discovery Product Solution and Service
3.7 Date of Enter into AI-driven Drug Discovery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AI-driven Drug Discovery Breakdown Data by Type
4.1 Global AI-driven Drug Discovery Historic Market Size by Type (2019-2024)
4.2 Global AI-driven Drug Discovery Forecasted Market Size by Type (2025-2030)
5 AI-driven Drug Discovery Breakdown Data by Application
5.1 Global AI-driven Drug Discovery Historic Market Size by Application (2019-2024)
5.2 Global AI-driven Drug Discovery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America AI-driven Drug Discovery Market Size (2019-2030)
6.2 North America AI-driven Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America AI-driven Drug Discovery Market Size by Country (2019-2024)
6.4 North America AI-driven Drug Discovery Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI-driven Drug Discovery Market Size (2019-2030)
7.2 Europe AI-driven Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe AI-driven Drug Discovery Market Size by Country (2019-2024)
7.4 Europe AI-driven Drug Discovery Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI-driven Drug Discovery Market Size (2019-2030)
8.2 Asia-Pacific AI-driven Drug Discovery Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific AI-driven Drug Discovery Market Size by Region (2019-2024)
8.4 Asia-Pacific AI-driven Drug Discovery Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI-driven Drug Discovery Market Size (2019-2030)
9.2 Latin America AI-driven Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America AI-driven Drug Discovery Market Size by Country (2019-2024)
9.4 Latin America AI-driven Drug Discovery Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI-driven Drug Discovery Market Size (2019-2030)
10.2 Middle East & Africa AI-driven Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa AI-driven Drug Discovery Market Size by Country (2019-2024)
10.4 Middle East & Africa AI-driven Drug Discovery Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Entos
11.1.1 Entos Company Detail
11.1.2 Entos Business Overview
11.1.3 Entos AI-driven Drug Discovery Introduction
11.1.4 Entos Revenue in AI-driven Drug Discovery Business (2019-2024)
11.1.5 Entos Recent Development
11.2 Selvita
11.2.1 Selvita Company Detail
11.2.2 Selvita Business Overview
11.2.3 Selvita AI-driven Drug Discovery Introduction
11.2.4 Selvita Revenue in AI-driven Drug Discovery Business (2019-2024)
11.2.5 Selvita Recent Development
11.3 Benevolent
11.3.1 Benevolent Company Detail
11.3.2 Benevolent Business Overview
11.3.3 Benevolent AI-driven Drug Discovery Introduction
11.3.4 Benevolent Revenue in AI-driven Drug Discovery Business (2019-2024)
11.3.5 Benevolent Recent Development
11.4 Exscientia
11.4.1 Exscientia Company Detail
11.4.2 Exscientia Business Overview
11.4.3 Exscientia AI-driven Drug Discovery Introduction
11.4.4 Exscientia Revenue in AI-driven Drug Discovery Business (2019-2024)
11.4.5 Exscientia Recent Development
11.5 Euretos
11.5.1 Euretos Company Detail
11.5.2 Euretos Business Overview
11.5.3 Euretos AI-driven Drug Discovery Introduction
11.5.4 Euretos Revenue in AI-driven Drug Discovery Business (2019-2024)
11.5.5 Euretos Recent Development
11.6 Illumina with AstraZeneca
11.6.1 Illumina with AstraZeneca Company Detail
11.6.2 Illumina with AstraZeneca Business Overview
11.6.3 Illumina with AstraZeneca AI-driven Drug Discovery Introduction
11.6.4 Illumina with AstraZeneca Revenue in AI-driven Drug Discovery Business (2019-2024)
11.6.5 Illumina with AstraZeneca Recent Development
11.7 Novo Nordisk with Microsoft
11.7.1 Novo Nordisk with Microsoft Company Detail
11.7.2 Novo Nordisk with Microsoft Business Overview
11.7.3 Novo Nordisk with Microsoft AI-driven Drug Discovery Introduction
11.7.4 Novo Nordisk with Microsoft Revenue in AI-driven Drug Discovery Business (2019-2024)
11.7.5 Novo Nordisk with Microsoft Recent Development
11.8 Iktos
11.8.1 Iktos Company Detail
11.8.2 Iktos Business Overview
11.8.3 Iktos AI-driven Drug Discovery Introduction
11.8.4 Iktos Revenue in AI-driven Drug Discovery Business (2019-2024)
11.8.5 Iktos Recent Development
11.9 Aqemia
11.9.1 Aqemia Company Detail
11.9.2 Aqemia Business Overview
11.9.3 Aqemia AI-driven Drug Discovery Introduction
11.9.4 Aqemia Revenue in AI-driven Drug Discovery Business (2019-2024)
11.9.5 Aqemia Recent Development
11.10 Zephyr AI
11.10.1 Zephyr AI Company Detail
11.10.2 Zephyr AI Business Overview
11.10.3 Zephyr AI AI-driven Drug Discovery Introduction
11.10.4 Zephyr AI Revenue in AI-driven Drug Discovery Business (2019-2024)
11.10.5 Zephyr AI Recent Development
11.11 Cyclicarx
11.11.1 Cyclicarx Company Detail
11.11.2 Cyclicarx Business Overview
11.11.3 Cyclicarx AI-driven Drug Discovery Introduction
11.11.4 Cyclicarx Revenue in AI-driven Drug Discovery Business (2019-2024)
11.11.5 Cyclicarx Recent Development
11.12 Eli Lilly
11.12.1 Eli Lilly Company Detail
11.12.2 Eli Lilly Business Overview
11.12.3 Eli Lilly AI-driven Drug Discovery Introduction
11.12.4 Eli Lilly Revenue in AI-driven Drug Discovery Business (2019-2024)
11.12.5 Eli Lilly Recent Development
11.13 Terray Therapeutics
11.13.1 Terray Therapeutics Company Detail
11.13.2 Terray Therapeutics Business Overview
11.13.3 Terray Therapeutics AI-driven Drug Discovery Introduction
11.13.4 Terray Therapeutics Revenue in AI-driven Drug Discovery Business (2019-2024)
11.13.5 Terray Therapeutics Recent Development
11.14 Ardigen
11.14.1 Ardigen Company Detail
11.14.2 Ardigen Business Overview
11.14.3 Ardigen AI-driven Drug Discovery Introduction
11.14.4 Ardigen Revenue in AI-driven Drug Discovery Business (2019-2024)
11.14.5 Ardigen Recent Development
11.15 ReviveMed
11.15.1 ReviveMed Company Detail
11.15.2 ReviveMed Business Overview
11.15.3 ReviveMed AI-driven Drug Discovery Introduction
11.15.4 ReviveMed Revenue in AI-driven Drug Discovery Business (2019-2024)
11.15.5 ReviveMed Recent Development
11.16 Insilico Medicine
11.16.1 Insilico Medicine Company Detail
11.16.2 Insilico Medicine Business Overview
11.16.3 Insilico Medicine AI-driven Drug Discovery Introduction
11.16.4 Insilico Medicine Revenue in AI-driven Drug Discovery Business (2019-2024)
11.16.5 Insilico Medicine Recent Development
11.17 XtalPi
11.17.1 XtalPi Company Detail
11.17.2 XtalPi Business Overview
11.17.3 XtalPi AI-driven Drug Discovery Introduction
11.17.4 XtalPi Revenue in AI-driven Drug Discovery Business (2019-2024)
11.17.5 XtalPi Recent Development
11.18 MindRank
11.18.1 MindRank Company Detail
11.18.2 MindRank Business Overview
11.18.3 MindRank AI-driven Drug Discovery Introduction
11.18.4 MindRank Revenue in AI-driven Drug Discovery Business (2019-2024)
11.18.5 MindRank Recent Development
11.19 DP Technology
11.19.1 DP Technology Company Detail
11.19.2 DP Technology Business Overview
11.19.3 DP Technology AI-driven Drug Discovery Introduction
11.19.4 DP Technology Revenue in AI-driven Drug Discovery Business (2019-2024)
11.19.5 DP Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global AI-driven Drug Discovery Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Small Molecule Drug
Table 3. Key Players of Biological Modeling
Table 4. Key Players of Structural Biology
Table 5. Key Players of Others
Table 6. Global AI-driven Drug Discovery Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global AI-driven Drug Discovery Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global AI-driven Drug Discovery Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global AI-driven Drug Discovery Market Share by Region (2019-2024)
Table 10. Global AI-driven Drug Discovery Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global AI-driven Drug Discovery Market Share by Region (2025-2030)
Table 12. AI-driven Drug Discovery Market Trends
Table 13. AI-driven Drug Discovery Market Drivers
Table 14. AI-driven Drug Discovery Market Challenges
Table 15. AI-driven Drug Discovery Market Restraints
Table 16. Global AI-driven Drug Discovery Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global AI-driven Drug Discovery Market Share by Players (2019-2024)
Table 18. Global Top AI-driven Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-driven Drug Discovery as of 2023)
Table 19. Ranking of Global Top AI-driven Drug Discovery Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by AI-driven Drug Discovery Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players AI-driven Drug Discovery Product Solution and Service
Table 23. Date of Enter into AI-driven Drug Discovery Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global AI-driven Drug Discovery Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global AI-driven Drug Discovery Revenue Market Share by Type (2019-2024)
Table 27. Global AI-driven Drug Discovery Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global AI-driven Drug Discovery Revenue Market Share by Type (2025-2030)
Table 29. Global AI-driven Drug Discovery Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global AI-driven Drug Discovery Revenue Market Share by Application (2019-2024)
Table 31. Global AI-driven Drug Discovery Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global AI-driven Drug Discovery Revenue Market Share by Application (2025-2030)
Table 33. North America AI-driven Drug Discovery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America AI-driven Drug Discovery Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America AI-driven Drug Discovery Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe AI-driven Drug Discovery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe AI-driven Drug Discovery Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe AI-driven Drug Discovery Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific AI-driven Drug Discovery Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific AI-driven Drug Discovery Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific AI-driven Drug Discovery Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America AI-driven Drug Discovery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America AI-driven Drug Discovery Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America AI-driven Drug Discovery Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa AI-driven Drug Discovery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa AI-driven Drug Discovery Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa AI-driven Drug Discovery Market Size by Country (2025-2030) & (US$ Million)
Table 48. Entos Company Detail
Table 49. Entos Business Overview
Table 50. Entos AI-driven Drug Discovery Product
Table 51. Entos Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)
Table 52. Entos Recent Development
Table 53. Selvita Company Detail
Table 54. Selvita Business Overview
Table 55. Selvita AI-driven Drug Discovery Product
Table 56. Selvita Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)
Table 57. Selvita Recent Development
Table 58. Benevolent Company Detail
Table 59. Benevolent Business Overview
Table 60. Benevolent AI-driven Drug Discovery Product
Table 61. Benevolent Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)
Table 62. Benevolent Recent Development
Table 63. Exscientia Company Detail
Table 64. Exscientia Business Overview
Table 65. Exscientia AI-driven Drug Discovery Product
Table 66. Exscientia Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)
Table 67. Exscientia Recent Development
Table 68. Euretos Company Detail
Table 69. Euretos Business Overview
Table 70. Euretos AI-driven Drug Discovery Product
Table 71. Euretos Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)
Table 72. Euretos Recent Development
Table 73. Illumina with AstraZeneca Company Detail
Table 74. Illumina with AstraZeneca Business Overview
Table 75. Illumina with AstraZeneca AI-driven Drug Discovery Product
Table 76. Illumina with AstraZeneca Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)
Table 77. Illumina with AstraZeneca Recent Development
Table 78. Novo Nordisk with Microsoft Company Detail
Table 79. Novo Nordisk with Microsoft Business Overview
Table 80. Novo Nordisk with Microsoft AI-driven Drug Discovery Product
Table 81. Novo Nordisk with Microsoft Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)
Table 82. Novo Nordisk with Microsoft Recent Development
Table 83. Iktos Company Detail
Table 84. Iktos Business Overview
Table 85. Iktos AI-driven Drug Discovery Product
Table 86. Iktos Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)
Table 87. Iktos Recent Development
Table 88. Aqemia Company Detail
Table 89. Aqemia Business Overview
Table 90. Aqemia AI-driven Drug Discovery Product
Table 91. Aqemia Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)
Table 92. Aqemia Recent Development
Table 93. Zephyr AI Company Detail
Table 94. Zephyr AI Business Overview
Table 95. Zephyr AI AI-driven Drug Discovery Product
Table 96. Zephyr AI Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)
Table 97. Zephyr AI Recent Development
Table 98. Cyclicarx Company Detail
Table 99. Cyclicarx Business Overview
Table 100. Cyclicarx AI-driven Drug Discovery Product
Table 101. Cyclicarx Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)
Table 102. Cyclicarx Recent Development
Table 103. Eli Lilly Company Detail
Table 104. Eli Lilly Business Overview
Table 105. Eli Lilly AI-driven Drug Discovery Product
Table 106. Eli Lilly Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)
Table 107. Eli Lilly Recent Development
Table 108. Terray Therapeutics Company Detail
Table 109. Terray Therapeutics Business Overview
Table 110. Terray Therapeutics AI-driven Drug Discovery Product
Table 111. Terray Therapeutics Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)
Table 112. Terray Therapeutics Recent Development
Table 113. Ardigen Company Detail
Table 114. Ardigen Business Overview
Table 115. Ardigen AI-driven Drug Discovery Product
Table 116. Ardigen Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)
Table 117. Ardigen Recent Development
Table 118. ReviveMed Company Detail
Table 119. ReviveMed Business Overview
Table 120. ReviveMed AI-driven Drug Discovery Product
Table 121. ReviveMed Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)
Table 122. ReviveMed Recent Development
Table 123. Insilico Medicine Company Detail
Table 124. Insilico Medicine Business Overview
Table 125. Insilico Medicine AI-driven Drug Discovery Product
Table 126. Insilico Medicine Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)
Table 127. Insilico Medicine Recent Development
Table 128. XtalPi Company Detail
Table 129. XtalPi Business Overview
Table 130. XtalPi AI-driven Drug Discovery Product
Table 131. XtalPi Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)
Table 132. XtalPi Recent Development
Table 133. MindRank Company Detail
Table 134. MindRank Business Overview
Table 135. MindRank AI-driven Drug Discovery Product
Table 136. MindRank Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)
Table 137. MindRank Recent Development
Table 138. DP Technology Company Detail
Table 139. DP Technology Business Overview
Table 140. DP Technology AI-driven Drug Discovery Product
Table 141. DP Technology Revenue in AI-driven Drug Discovery Business (2019-2024) & (US$ Million)
Table 142. DP Technology Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global AI-driven Drug Discovery Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global AI-driven Drug Discovery Market Share by Type: 2023 VS 2030
Figure 3. Small Molecule Drug Features
Figure 4. Biological Modeling Features
Figure 5. Structural Biology Features
Figure 6. Others Features
Figure 7. Global AI-driven Drug Discovery Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global AI-driven Drug Discovery Market Share by Application: 2023 VS 2030
Figure 9. Pharmaceutical and Biotechnology Companies Case Studies
Figure 10. Research Laboratories Case Studies
Figure 11. AI-driven Drug Discovery Report Years Considered
Figure 12. Global AI-driven Drug Discovery Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global AI-driven Drug Discovery Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global AI-driven Drug Discovery Market Share by Region: 2023 VS 2030
Figure 15. Global AI-driven Drug Discovery Market Share by Players in 2023
Figure 16. Global Top AI-driven Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-driven Drug Discovery as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by AI-driven Drug Discovery Revenue in 2023
Figure 18. North America AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America AI-driven Drug Discovery Market Share by Country (2019-2030)
Figure 20. United States AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe AI-driven Drug Discovery Market Share by Country (2019-2030)
Figure 24. Germany AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific AI-driven Drug Discovery Market Share by Region (2019-2030)
Figure 32. China AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America AI-driven Drug Discovery Market Share by Country (2019-2030)
Figure 40. Mexico AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa AI-driven Drug Discovery Market Share by Country (2019-2030)
Figure 44. Turkey AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia AI-driven Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Entos Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)
Figure 47. Selvita Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)
Figure 48. Benevolent Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)
Figure 49. Exscientia Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)
Figure 50. Euretos Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)
Figure 51. Illumina with AstraZeneca Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)
Figure 52. Novo Nordisk with Microsoft Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)
Figure 53. Iktos Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)
Figure 54. Aqemia Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)
Figure 55. Zephyr AI Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)
Figure 56. Cyclicarx Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)
Figure 57. Eli Lilly Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)
Figure 58. Terray Therapeutics Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)
Figure 59. Ardigen Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)
Figure 60. ReviveMed Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)
Figure 61. Insilico Medicine Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)
Figure 62. XtalPi Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)
Figure 63. MindRank Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)
Figure 64. DP Technology Revenue Growth Rate in AI-driven Drug Discovery Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
